Clinical Trial: A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584
Brief Summary: This is a safety, efficacy and pharmacokinetics study of the fixed combination of AGN-199201 and AGN-190584 in participants with presbyopia (inability to focus on items close-up).
Detailed Summary:
Sponsor: Allergan
Current Primary Outcome: Average Change from Baseline in Uncorrected Near Visual Acuity (UNVA) Letters [ Time Frame: Baseline, Day 28 ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Allergan
Dates:
Date Received: May 19, 2016
Date Started: May 2016
Date Completion: June 2017
Last Updated: December 6, 2016
Last Verified: December 2016